STERIS plc (STE)

STERIS plc (STE) is a healthcare company (medical devices) based in the United States. The share price is $260.50, down 0.28% on the day, which values the company at $25.3B. Price as of 17 Nov 2026, 17:15 UTC, from Yahoo Finance.

Key facts

Share price
$260.50−0.28% today
Market value
$25.3B
P/E ratio
30.9×last 12 months
Forward P/E
20.9×
Dividend yield
0.99%
Funk Score
69/100
Against its own history
About its usual priceusual price $280.11
200-week average
$224.5516% above

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

STERIS plc in more detail

STE trades at 30.9× its last twelve months' earnings, 20.9× next year's expected earnings, 4.1× sales. Measured against its own history, the price is 7% below what its usual multiples would imply ($280.11) — about its usual price. It sits 16% above its 200-week average of $224.55.

Over the last five fiscal years STERIS plc has compounded revenue 13.8% a year, earnings per share 11.4% a year, free cash flow 16.6% a year. Its Funk Score is 69 out of 100 (financial strength 8.0, profitability 7.4, growth 7.3, value 5.0, each out of 10).

In its favour: Altman Z in the safe zone; Strong Piotroski score.

1 of the superinvestors tracked here hold STE, including Joel Greenblatt (0.1% of the portfolio).

Superinvestors holding STE

1 of the investors tracked here report a position in their latest 13F filing.

Compare

Health Care companies of similar size

Side by side:STE vs INSM (STERIS plc vs Insmed)STE vs UTHR (STERIS plc vs United Therapeutics)STE vs INCY (STERIS plc vs Incyte)STE vs VTRS (STERIS plc vs Viatris)STE vs THC (STERIS plc vs Tenet Healthcare)

All health care companies by market valueLargest companies in IrelandAll stocks A–Z

STERIS plc (STE): questions and answers

What is STE's P/E ratio?

STERIS plc trades at 30.9× its last twelve months' earnings and 20.9× next year's expected earnings. At its fiscal year-ends over the past 10 years the P/E ranged from 27.5× to 178.8×, with a median of 38.8×.

What is STE's PEG ratio?

STERIS plc's PEG ratio is 2.58 — its P/E divided by its expected earnings growth. Around 1 is the classic sign of a price that matches the growth; well above it means the growth is being paid for in advance.

What is STERIS plc's market cap?

STERIS plc is valued at $25.3B at a share price of $260.50.

Is STE overvalued or undervalued?

Against its own history, STE is about its usual price: the price is 7% below the $280.11 implied by the median multiples it has traded at (price / earnings, price / sales, price / book, price / free cash flow). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is STE above its 200-week moving average?

Yes. STE is 16.0% above its 200-week average of $224.55. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is STERIS plc growing?

Over the last five fiscal years STERIS plc's revenue grew 13.8% a year and its earnings per share 11.4% a year.

Cite this page

Funkfolio, “STERIS plc (STE) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/STE

Underlying data: Yahoo Finance; company filings with the SEC.